Article Details
Retrieved on: 2024-08-25 23:25:28
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Amgen's biotechnological advancements and financial results, highlighting increased revenue due to product sales, including drugs targeting lung cancer and other diseases. The key concept and tags connect through Amgen's biotech strategies to enhance oncology treatments with drugs like Nplate, Blinatumomab, and Pembrolizumab.
Article found on: investingnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here